From: FGFR1 is amplified during the progression of in situto invasive breast carcinoma
Characteristic | n(%) |
---|---|
Pure DCIS | 179 |
Age (years) | Â |
   Mean (range) | 50 (26 to 82) |
Grade | Â |
   Low | 16 (8.9) |
   Intermediate | 85 (47.5) |
   High | 78 (43.6) |
Invasive carcinomas | 438 |
Age (years) | Â |
   Mean (range) | 50 (21 to 87) |
Stage | Â |
   I | 143 (32.6) |
   II | 235 (53.7) |
   III | 55 (12.6) |
   IV | 5 (1.1) |
Histologic subtype | Â |
   Invasive ductal carcinoma | 397 (90.6) |
   Invasive lobular carcinoma | 14 (3.2) |
   Mucinous carcinoma | 12 (2.7) |
   Metaplastic carcinoma | 5 (1.1) |
   Tubular carcinoma | 3 (0.7) |
   Others | 7 (1.6) |
Histologic grade | Â |
   Grade I | 88 (20.1) |
   Grade II | 148 (33.8) |
   Grade III | 188 (42.9) |
   Not determined | 14 (3.2) |
Grade of associated DCISa | Â |
   Low | 10 (4.6) |
   Intermediate | 100 (46.3) |
   High | 106 (49.1) |